Reproducibility starts with the vial
Helix Club exists because too much research supply arrives undocumented. When you cannot verify what is in the vial, every result downstream of it inherits that uncertainty.
We manufacture in the United States, test every lot through an accredited third-party laboratory, and publish the results permanently — whether or not anyone asks to see them.
Three commitments we do not negotiate
Documentation first
A compound without a certificate is an unknown. Every lot we release publishes its full QC panel — and those results stay online after the lot sells out.
One standard, no tiers
There is no premium grade and economy grade here. Every vial comes off the same line, through the same seven-point panel, at the same 99%+ release specification.
Priced for the bench
In-house U.S. manufacturing removes the distributor layers that put high-purity supply out of reach of small labs and independent researchers.
How we got here
2023
Founded
Started after a failed replication traced back to mislabeled material from a third-party supplier.
2024
In-house synthesis
Brought manufacturing in-house in the United States to control the process end to end.
2025
Public lot history
Began publishing every certificate permanently, including historical lots.
2026
Seven-point panel
Expanded release testing to include endotoxin and sterility screening on every lot.
Research updates from Helix Club
Catalog updates, new research compounds, and quality documentation news.
For researchers and labs. No spam, unsubscribe anytime.